ABCG2 and cancer: ABCG2 has been widely reported to be a principal cause of MDR in various cancers via extruding various antineoplastic drugs such as tyrosine kinase inhibitors (TKIs), topoisomerase inhibitors, anthracyclines, etc. 25-29.